EFFECT OF SHRINGYADI LEHA IN THE TREATMENT OF KAPHAJA KASA IN CHILDREN - A RANDOMIZED CONTROL CLINICAL STUDY
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Shringyadi leha may become safe and cost effective treatment for Kaphaja kasa, when compared to proven drug Talisadi churna which contains 7 ingredients and comparatively more costly.
研究概览
简要总结
Due to many environmental changes and less immune responses the respiratory tract infections are increasing day by day , among these 50% patients attends the pediatrics opd.At Primary Health Care Centres the study has been carried out by pediatrics department , in which 71% respiratory complaints are noticed, Recurrent attacks of kaphajakasa shows a prevalence rate of 1.06%, among them maximum no. of cases of study were seen in the age of 5 years to10 years, It is important to treat any disease in childhood age as the earliest as it may hamper the growth and development of the child.There are a large no. of expectorents drugs are available for management of cough in present time , but their bacterial resistance development and large no. of complications and side effects noticed day to day , So it’s better to give a safe and effective alternative management for this. According to Ayurveda , shaman line of treatment that included oral administration of medicine is very easy and also effective compared to shodhana in children.In this study we have planned to study subjects of kaphajakasa with combination of herbal drug and diet, Many herbal combinations for shaman chikitsa are described in Ayurveda and their therapeutic efficacy in kasa is yet to be explored, so the present study has been undertaken to evaluate the effect of shringyadileha to treat kaphajakasa in children
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Open Label
入排标准
- 年龄范围
- 4.00 Year(s) 至 10.00 Year(s)（—）
- 性别
- All
入选标准
- •Children of either sex between the age group 4 years to 10 years
- •Patients with any of two or more symptoms described in the context
- •KaphajaKasa of less than 15 days duration will be selected.
排除标准
- •Patients with kasa- except kaphajakasa.
- •Kasa as anubandh lakshana and updrava in other systemic diseases
- •Patients age below 4 years and above 10 years.
- •COPD cases and tuberculosis patients.
结局指标
主要结局
Shringyadi leha may become safe and cost effective treatment for Kaphaja kasa, when compared to proven drug Talisadi churna which contains 7 ingredients and comparatively more costly.
时间窗: Shringyadi leha may become safe and cost effective treatment for Kaphaja kasa, when compared to proven drug Talisadi churna which contains 7 ingredients and comparatively more costly. | Duration of treatment is less for 7days- may be effective in less period of time .
Duration of treatment is less for 7days- may be effective in less period of time .
时间窗: Shringyadi leha may become safe and cost effective treatment for Kaphaja kasa, when compared to proven drug Talisadi churna which contains 7 ingredients and comparatively more costly. | Duration of treatment is less for 7days- may be effective in less period of time .
次要结局
- Reduction of symptoms of Kaphaja Kasa within 7 days of duration.(7 days)